The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained

Kirsten Dirkx, Bert Mulder, Annelies Post, Martijn Rutten, Caroline Swanink, Heiman Wertheim, Amelieke Cremers
doi: https://doi.org/10.1101/2021.06.29.21259494

Article Information

doi 
https://doi.org/10.1101/2021.06.29.21259494
History 
  • July 3, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Kirsten Dirkx1,2,*,
  2. Bert Mulder1,
  3. Annelies Post1,
  4. Martijn Rutten3,
  5. Caroline Swanink4,
  6. Heiman Wertheim2 and
  7. Amelieke Cremers2
  1. 1Department of Clinical Microbiology and Infectious Diseases, Canisius-Wilhelmina Ziekenhuis, Nijmegen, the Netherlands
  2. 2Department of Clinical Microbiology, Radboud Centre for Infectious Diseases, Radboudumc, Nijmegen, the Netherlands
  3. 3Department of Primary and Community Care, Radboud University Medical Centre, Nijmegen, The Netherlands
  4. 4Department of Clinical Microbiology and Immunology, Rijnstate, Arnhem, the Netherlands
  1. ↵* Corresponding author; email: k.dirkx{at}student.ru.nl
Back to top
Posted July 03, 2021.
Download PDF
Data/Code
Email
The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained
Kirsten Dirkx, Bert Mulder, Annelies Post, Martijn Rutten, Caroline Swanink, Heiman Wertheim, Amelieke Cremers
medRxiv 2021.06.29.21259494; doi: https://doi.org/10.1101/2021.06.29.21259494
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area